Others

Sun Pharmaceutical Industries Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on March 01, 2019 Published on March 01, 2019

Please find enclosed herewith our Press Release relating to ILUMYA (tildrakizumab-asmn) 3-Year Data Demonstrates Sustained Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis, which we shall be releasing after sending this letter to you. This is for your information and record.

Thanking you,

Pdf Link: Sun Pharmaceutical Industries Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on March 01, 2019
This article is closed for comments.
Please Email the Editor